CRYSTAL PEEL
Originaltext auf Französisch.
In Kanada zugelassenes natürliches Gesundheitsprodukt
Die Analyse oraler Dosen ist ohne einen nachgewiesenen ausschließlich oralen Verabreichungsweg nicht anwendbar.
Zusammensetzung
| Arzneilicher Inhaltsstoff und Quelle | Je Dosiseinheit laut Quelle |
|---|---|
| Acide 2-hydroxybenzoïque Quelle : Acide salicylique | 20 % (v/v) |
Nicht arzneiliche Inhaltsstoffe
Acide phosphorique, Eau, SD alcool 40-A
In Kanada empfohlene Dosen
| Bevölkerungsgruppe | Alter | Menge pro Einnahme | Häufigkeit |
|---|---|---|---|
| Adultes | minimum : 18 ans | Non précisée | Non précisée |
In Kanada zugelassene Verwendungen
Acne treatment. Intended for the treatment of Mild Acne & Hyperkeratosis. Intended for the treatment of Melasma, solar and senile lentigines and post inflammatory pigmentation.
Originaltext auf Englisch.
Eine in Kanada zugelassene Verwendung ist keine in der Europäischen Union zugelassene gesundheitsbezogene Angabe. Beachten Sie das Register gesundheitsbezogener Angaben.
Warnhinweise in Kanada
Known Adverse Reactions : Allergy alert get medical help right away if the patient develops hives, swelling of eyes and mouth, blistering, or difficulty breathing. Stop use if patient develops severe irritation, burning/itching of the skin, pigmentation, or milia. Use with caution in patients who have a recent history of smoking, herpes simplex, dermatitis, psoriasis, or any other inflammatory condition in the skin area to be treated Use with caution in patients who suffer from immunosuppression, or are taking oral contraceptives or tetracyclines Use with caution in patients who have recently had medical or cosmetic treatment or procedure (e.g., laser therapy, surgical procedures, cosmetic filler, microdermabrasion, etc.) Do not use on inflamed, broken or infected skin. Do not use in patients with vitiligo, diabetes, active cold sores, or poor blood circulation, or who currently suffer from any type of infection Do not apply to large areas of the body. Do not apply under occlusion (as this may cause salicylism, characterized by tinnitus, dizziness, abdominal cramps, and deafness) Do not use if patient is allergic to acetylsalicylic acid or other salicylates.
Originaltext auf Englisch.
Cautions and Warnings : For external use only. Keep out of reach of children. If swallowed, call a poison control centre or get medical help right away. When using this product skin irritation and dryness are more likely to occur when using another topical acne product at the same time. If irritation occurs, use only one product at a time. When using this product, avoid contact with eyes. If contact occurs, rinse thoroughly with water. Avoid contact with mucous membranes such as nose and lips; protect these sensitive areas with a moisturizer or petrolatum-based agent. In case of contact, rinse thoroughly with water. If irritation persists, discontinue use and seek medical attention. Do not use on an irritated area, facial herpes, skin allergy or after taking retinoids (or any potentially irritating substance), eye contour and perioral area. Consult a health care practitioner if symptoms persist or worsen. Skin contact should be of limited frequency and duration. One week before the treatment, do not perform hair removal or electrolysis on the area to be treated. Four hours before the treatment, do not shave the affected area. The use of depilatory agents, waxes, depilatory lasers, exfoliating sponges and masks must be discontinued one week before the treatment. For Professional use only. Not for Retail Sale. Please limit sun exposure and apply a sunburn protectant for a week after using this product
Originaltext auf Englisch.
Contra-Indications : Do not use in patients who are pregnant or breastfeeding. Use with caution in patients who have HIV or have undergone treatment with dermabrasion or ablative resurfacing within the past 12 months. Do not use if the patient suffers from flat warts, or from a viral dermatological infection such as molloscum contagiosum. Do not use in patients who have taken isotretinoin in the past 12 months, have received recent chemotherapy or radiation therapy, or are taking photosensitizing medication. These side effects are frequently observed: burning, dermatitis, blisters, redness, swelling, itching, peeling, rash, dryness and skin lesions.
Originaltext auf Englisch.
Produktdaten
- Andere Namen
- Superficial Chemical Peel
- Inhaber
- 2625686 ONTARIO INC dba NUVIOR
- NPN oder DIN-HM
- 80124648
- Status
- Aktive Lizenz
- Lizenzdatum
- 25. Mai 2023
- Überarbeitungsdatum
- Nicht angegeben
- Form
- Liquide topique
- Verabreichungsweg
- Topique
- Art des Antrags
- Générale (non traditionelle)
Quelle
Amtlicher Health-Canada-Eintrag, Zulassung 80124648
Licensed Natural Health Products Database (LNHPD), Health Canada: zugelassene Produkte, Inhaltsstoffe, Dosierungen, Verwendungen und Warnhinweise, abgerufen am 27. Oktober 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Originaltext auf Englisch.
Originaltext auf Französisch.
Die unter demselben Namen in Europa verkaufte Rezeptur kann abweichen. Diese Angaben ersetzen keinen ärztlichen oder pharmazeutischen Rat.
Das Belegdatum dieser Zutatenliste ist unbekannt.
Das Produkt hat sich geändert? Fotografieren Sie die Verpackung.
Ist eine Angabe zu diesem Produkt falsch oder veraltet, ob Sie Leser oder Marke sind? Schreiben Sie an contact@compoatlas.com: Jede Korrektur wird im Korrekturprotokoll veröffentlicht.